-

Shareholder Alert: Robbins LLP is Investigating the Officers and Directors of Fifth Third Bancorp (FITB) on Behalf of Shareholders

SAN DIEGO & CINCINNATI--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Fifth Third Bancorp (NASDAQ: FITB) for potential material misstatements and violations of federal securities laws pursuant to its March 2019 acquisition of MB Financial, Inc. On March 21, 2018, Fifth Third Bancorp and MB Financial announced the signing of a merger agreement in which MB Financial would merge with Fifth Third in a transaction valued at approximately $4.7 billion. Shareholders of MB Financial received 1.45 shares of Fifth Third common stock and $5.54 in cash for each share of MB Financial common stock they owned. The merger was completed on March 22, 2019. Since the merger, shares of Fifth Third have declined precipitously, and it currently trades at around $18 per share.

If you received shares of Fifth Third Bancorp stock in the March 2019 acquisition, click here.

Fifth Third Bancorp (FITB) Shareholders Have Legal Options

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Fifth Third settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
llevi@robbinsllp.com
(800) 350-3990 or (619) 525-3990
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Vistagen Therapeutics, Inc. Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Vistagen Therapeutics, Inc. (NASDAQ: VTGN) common stock between April 1, 2024 and December 16, 2025. Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. For more information, submit a form, email attorney Aaron Dumas...

Investor Notice: Robbins LLP Informs Investors of the Securities Class Action Against Oracle Corporation

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a class action was filed on behalf of all persons and/or entities who purchased or otherwise acquired Oracle Corporation (NYSE: ORCL) Senior Notes issued pursuant to the Shelf Registration Statement filed with the SEC on March 15, 2024, and as supplemented on September 25, 2025. Oracle is an Austin, Texas-based company that sells database software, enterprise applications, and cloud infrastructure and hardware. For more information,...

Investor Notice: Robbins LLP Informs Investors of the Smart Digital Group Limited Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Smart Digital Group Limited (NASDAQ: SDM) securities between May 5, 2025 and September 26, 2025. Smart Digital, together with its subsidiaries, provides internet media, business planning and consulting, event planning and execution, and software customization and marketing services in Mainland China and Macau. For more information, submit a fo...
Back to Newsroom